Provided is a multilayered container including a polyester layer containing a thermoplastic polyester resin (X) and a polyamide layer containing a polyamide resin (Y), wherein the polyester layer is an innermost layer, and the polyamide layer is an intermediate layer. The polyamide resin (Y) has a constituent unit derived from a diamine and a constituent unit derived from a dicarboxylic acid. At least 70 mol % of the constituent units derived from a diamine are a constituent unit derived from a xylylenediamine, and at least 70 mol % of the constituent units derived from a dicarboxylic acid are a constituent unit derived from an α,ω-linear aliphatic dicarboxylic acid having from 4 to 20 carbons. When an overall thickness is 100%, the polyamide layer is present from a position of 5 to 35% from an inner surface, and a thickness of the polyamide layer is from 1 to 15%.

An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product. The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product. The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

A support plate (100, 150) for supporting a package (200) during filling with a foot product is disclosed. The support plate (100, 150) comprises a wall (104, 154) defining a cavity (112, 162) for receiving a top portion (212, 216) of the package (200). The wall (104, 154) has a slanted interior surface (108, 158) that is complementary to the top portion (212, 216) of the package (200). The support plate (100, 150) also comprises a support projection (116, 166) extending in a parallel direction to and away from the wall (104, 154), the support projection (116, 166) being complementary to and for abutting the top portion comprising a concave top surface (216) and a concave surface (208) of the package (200). A system (320) comprising the support plate (100, 150) for use in a filling machine (400) and a filling machine (400) comprising a plurality of the systems (320) are also disclosed.

An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product, including a granulocyte colony-stimulating factor (G-CSF). The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product, including a granulocyte colony-stimulating factor (G-CSF). The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

The present invention relates to a container adapted to dispense its content under pressure. The container of the present invention consists of two separate compartments separated from one another by a slidable piston. The container of the present invention contains a haemostatic paste.

The present invention relates to a container adapted to dispense its content under pressure. The container of the present invention consists of two separate compartments separated from one another by a slidable piston. The container of the present invention contains a haemostatic paste.

A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be used in a clean room to deactivate most hazardous drugs on a work surface.

A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be used in a clean room to deactivate most hazardous drugs on a work surface.